SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001328143-21-000071
Filing Date
2021-08-09
Accepted
2021-08-09 16:01:42
Documents
68
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q adms-20210630.htm   iXBRL 10-Q 1447219
2 EX-2.2 adms10qq22021ex22.htm EX-2.2 28752
3 EX-31.1 adms10qq22021ex311.htm EX-31.1 11549
4 EX-31.2 adms10qq22021ex312.htm EX-31.2 11916
5 EX-32.1 adms10qq22021ex321.htm EX-32.1 8718
11 adamaslogo.jpg GRAPHIC 3891
  Complete submission text file 0001328143-21-000071.txt   5963855

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT adms-20210630.xsd EX-101.SCH 35325
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT adms-20210630_cal.xml EX-101.CAL 64791
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT adms-20210630_def.xml EX-101.DEF 189411
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT adms-20210630_lab.xml EX-101.LAB 495136
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT adms-20210630_pre.xml EX-101.PRE 318399
12 EXTRACTED XBRL INSTANCE DOCUMENT adms-20210630_htm.xml XML 882952
Mailing Address 1900 POWELL ST., SUITE 1000 EMERYVILLE CA 94608
Business Address 1900 POWELL ST., SUITE 1000 EMERYVILLE CA 94608 510-450-3554
Adamas Pharmaceuticals Inc (Filer) CIK: 0001328143 (see all company filings)

IRS No.: 421560076 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36399 | Film No.: 211156352
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences